APA-referens (7:e uppl.)

Fritz, I., Wagner, P., Bottai, M., Eriksson, H., Ingvar, C., Krakowski, I., . . . Lund University, P. a. a. o. s. r. e. (2020). Desloratadine and loratadine use associated with improved melanoma survival. Allergy Improved cancer survival with use of common antihistamines. Epidemiological studies on the use of H1-antihistamines and survival in cancer., 75(8), 2096. https://doi.org/10.1111/all.14273

Chicago-referens (17:e uppl.)

Fritz, Ildikó, et al. "Desloratadine and Loratadine Use Associated with Improved Melanoma Survival." Allergy Improved Cancer Survival with Use of Common Antihistamines. Epidemiological Studies on the Use of H1-antihistamines and Survival in Cancer. 75, no. 8 (2020): 2096. https://doi.org/10.1111/all.14273.

MLA-referens (9:e uppl.)

Fritz, Ildikó, et al. "Desloratadine and Loratadine Use Associated with Improved Melanoma Survival." Allergy Improved Cancer Survival with Use of Common Antihistamines. Epidemiological Studies on the Use of H1-antihistamines and Survival in Cancer., vol. 75, no. 8, 2020, p. 2096, https://doi.org/10.1111/all.14273.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.